Cargando…

Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716654/ https://www.ncbi.nlm.nih.gov/pubmed/31469880 http://dx.doi.org/10.1371/journal.pone.0222176

Ejemplares similares

The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
por: Zhang, Qing, et al.
Publicado: (2012)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Publicado: (2019)

Retracted: Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

Retraction: Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure
Publicado: (2019)

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
Publicado: (2019)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
Publicado: (2019)

Retracted: Clinical Nursing Paths Benefit Patient Outcomes Undergoing Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: The Clinical Value of Thyroid Hormone Levels and Correlation with Severity of Liver Cirrhosis
por: Neuroscience, Computational Intelligence and
Publicado: (2023)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Publicado: (2019)

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation
Publicado: (2019)

Retracted: Analysis of Clinical Characteristics of Hepatitis B and Alcohol-Related Liver Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retraction: An Occult Hepatitis B-Derived Hepatoma Cell Line Carrying Persistent Nuclear Viral DNA and Permissive for Exogenous Hepatitis B Virus Infection
Publicado: (2021)

Retracted: Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl(4)-Induced Liver Cirrhosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2017)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Retracted: Serum Expression Level of MicroRNA-122 and Its Significance in Patients with Hepatitis B Virus Infection
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
por: International, BioMed Research
Publicado: (2023)

Retracted: Clinical Diagnostic Value of Quantitative Hepatitis B Virus Core Antibody Test in Chronic Viral Hepatitis B
por: and Applications, Bioinorganic Chemistry
Publicado: (2023)

Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation
Publicado: (2019)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis
por: International, BioMed Research
Publicado: (2023)

Retracted: A Meta-Analysis of the Influence of Tumor Necrosis Factor-α-308 Gene Polymorphism on Liver Cirrhosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Intravenous Drip of Somatostatin Followed by Restricted Fluid Resuscitation to Treat Upper Gastrointestinal Bleeding in Patients with Liver Cirrhosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

[Retracted] microRNA‑196b promotes cell migration and invasion by targeting FOXP2 in hepatocellular carcinoma
por: Yu, Zhaoxiang, et al.
Publicado: (2023)

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016)

Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: BioMed Research International,
Publicado: (2018)

Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
por: International, BioMed Research
Publicado: (2021)

[Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo
por: Wang, Xing, et al.
Publicado: (2023)

Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2021)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure
Publicado: (2019)

Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research
por: International, BioMed Research
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ujhm09ab5r1hqh66tqaki4g1bs